Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

icons/content-types/fact sheet fact sheet

It is important to have both a clear, science-based understanding of how the amorphous active drug is formed and also a comprehensive characterization of its fundamental properties, such as Tg, water vapor sorption, and relaxation time as a function...

icons/content-types/article article

Two isomers of Mogroside VI, Mogroside VIa1 (1) and Mogroside VIa (2), were isolated from the extracts of Luo Han Guo. Compound 1 is a newly isolated isomer of Mogroside VI. We report here detailed structural confirmation of the structures of 1 and 2...

icons/content-types/infographic infographic

Curia has remained on the cutting-edge of package testing technology with state-of-the-art programs for assessing package system integrity. Within the pharmaceutical industry Container Closure Integrity Testing (CCIT) is crucial in ensuring safety an...

icons/content-types/article article

Demands to rapidly advance drugs while minimizing cost as well as maintaining sterility assurance and high safety standards are accelerating the pace of change across the fill/finish industry.  As medicines shift from one-size-fits-all treatments to...

icons/content-types/fact sheet fact sheet

Curia provides cGMP dissolution support for APIs and a wide variety of dosage forms in various buffered, biorelevant, and mixed organic-phase media.  We have capability with various USP dissolution apparatus, including multi scale and automated rota...

icons/content-types/article article

From target discovery through launching a finished product to market, developing a new drug is a complex process which takes on average 10-15 years and costs around 2.6 billion dollars. Early on, this process often involves a high-throughput screenin...

icons/content-types/article article

With increasing antibiotic resistance observed amongst clinical isolates of Neisseria gonorrhoeae, the second most prevalent sexually transmitted bacterial disease in the United States, there is still a need for antimicrobial susceptibility testing...

040E93C7-D189-4233-A102-58C0580BE529 publications patents

Between 2005 and 2019, there have been over 350 published pieces and nearly 300 patents that AMRI has released.

040E93C7-D189-4233-A102-58C0580BE529 publications patents

The following research articles appeared in peer-reviewed scientific journals that described innovations conceived by AMRI scientists. In most of these cases, these manuscripts were written by AMRI lead authors to communicate independent research, or...

icons/content-types/article article

A panel of experts share their views on some of the critical issues facing the pharmaceutical industry in regards to API sourcing, new API technical services or manufacturing technologies, guidance on choosing a supplier for API research/development...

icons/content-types/video webinar

Are you looking for the right contract development and manufacturing organization (CDMO) to develop and manufacture your high potency active pharmaceutical ingredients (HPAPIs)? Or have you been unsure about the CDMO you’re currently working with...

icons/content-types/article article

A novel polymorph of ROY was found by thermal methods. The crystal structure was solved by matching calculated powder X-ray diffraction patterns from a previously published crystal structure prediction to the experimental data. The structure was furt...